Corcept Therapeutics
CORT
CORT
225 hedge funds and large institutions have $1.81B invested in Corcept Therapeutics in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 64 increasing their positions, 94 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
21% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 34
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
32% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 94
Holders
225
Holding in Top 10
3
Calls
$2.07M
Puts
$1.48M
Top Buyers
| 1 | +$13.7M | |
| 2 | +$8.13M | |
| 3 | +$6.93M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$6.08M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$5M |
Top Sellers
| 1 | -$34.9M | |
| 2 | -$25M | |
| 3 | -$18.7M | |
| 4 |
HSBC Holdings
London,
United Kingdom
|
-$14.7M |
| 5 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$11.5M |